High-mobility group box 1 is a promising diagnostic and therapeutic monitoring biomarker in Cancers: A review
High-mobility group box 1 (HMGB1) is universally found in the nuclei and cytosols of mammalian cells. Excessive secretion of HMGB1 is concomitant with unrestricted replicative capabilities, angiogenesis, apoptosis, self-reliance in growth signals, neutrality to growth inhibitors, inflammation, tissu...
Main Author: | Seidu A. Richard |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2018-11-01
|
Series: | AIMS Molecular Science |
Subjects: | |
Online Access: | http://www.aimspress.com/article/10.3934/molsci.2018.4.183/fulltext.html |
Similar Items
-
Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review
by: Seidu A. Richard
Published: (2019-12-01) -
Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients
by: Nikolaus A. Handke, et al.
Published: (2021-02-01) -
Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and Therapy
by: Grigorios Plemmenos, et al.
Published: (2023-07-01) -
Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
by: Mira C. Patel, et al.
Published: (2018-05-01) -
Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics
by: Bryan Gervais de Liyis, et al.
Published: (2022-10-01)